D. Stoermer

发表

Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.

D. Ferraris, T. Tsukamoto, B. Slusher, 2012, Journal of medicinal chemistry.

a Positron-Emitting Agonist for Peroxisome Proliferator-Activated Receptor-

M. Pomper, R. Dannals, H. Ravert, 2005 .

Synthesis and Biodistribution of 11C-GW7845, a Positron-Emitting Agonist for Peroxisome Proliferator–Activated Receptor-γ

M. Pomper, R. Dannals, H. Ravert, 2005 .

Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Qun Liu, T. Tsukamoto, B. Slusher, 2006, Journal of medicinal chemistry.

Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.

Qun Liu, T. Tsukamoto, B. Slusher, 2003, Journal of medicinal chemistry.

Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.

X. C. Lu, T. Tsukamoto, B. Slusher, 2001, Journal of medicinal chemistry.

Total synthesis of zaragozic acid A (squalestatin S1). Synthesis of the relay compound

S. Caron, C. Heathcock, D. Stoermer, 1996 .

Calicheamicin−Homeodomain Conjugate as an Efficient, Sequence-Specific DNA Cleavage and Mapping Tool

C. Townsend, D. Stoermer, Minwan Wu, 2000 .

Total synthesis of (-)-alloaristoteline, (-)-serratoline, and (+)-aristotelone

C. Heathcock, D. Stoermer, Doris Stoermer, 1993 .

Total Synthesis of Zaragozic Acid A (Squalestatin S1). Degradation to a Relay Compound and Reassembly of the Natural Product

S. Caron, C. Heathcock, D. Stoermer, 1996 .

Total Synthesis of Zaragozic Acid A (Squalestatin S1) (I). Degradation to a Relay Compound (II) and Reassembly of the Natural Product.

S. Caron, C. Heathcock, D. Stoermer, 1997 .

Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.

Monicia R. Hall, Qun Liu, T. Tsukamoto, 2003, Bioorganic & medicinal chemistry letters.